Charles A. Gilson III
**** *** *** ******, *** Diego, CA 92107 ( 858-***-**** (
********@*****.***
[pic]
OBJECTIVE
I am seeking a full-time chemistry related career that can make use of my
8+ years of industrial experience synthesizing and characterizing small
molecules for use in drug discovery. I am presently employed with Biogen
Idec here in San Diego, but my current position is being relocated to
Boston, Mass. at the end of this year.
SKILLS
. Over seven years of industrial experience involving the multi-step
synthesis and characterization of small, novel heterocyclic compounds
for use in early stage drug discovery.
. One year of small molecule preformulation experience performing
physical and chemical evaluation of early-to-late stage drug
development candidates.
. Proven success record of academic and professional experience working
on a variety of exploratory projects involving route development, hit-
to-lead identification, and scale-up projects from microscale to the
multi-gram level.
. Extensive experience with small molecule isolation and
characterization utilizing preparatory/analytical HPLC, 1 and 2-D NMR,
LCMS, IR, GCMS, microwave synthesis and numerous automated
chromatography instruments.
. Conducted experiments to evaluate the pharmaceutical properties of
drug development candidates using DSC, TGA, XRPD, microscopy, moisture
sorption, FTIR, RAMAN, HPLC (Empower software) and dissolution
analysis.
. Crystallization and solid state characterization for salt and
polymorph selection of clinical candidates.
. Extensive use of Beilstein, Scifinder and ChemGate database systems.
. NMR maintenance including weekly nitrogen fills and periodic helium
fills.
. Responsible for the maintenance and upkeep of numerous instrument
systems including Waters Deltaprep HPLC's, CEM microwave synthesizers,
PAR hydrogenators, ect.
. Past experience working as a Highway Patrolman for the State of
Virginia
PROFESSIONAL EXPERIENCE
Biogen-Idec Inc, San Diego, CA
Associate Scientist II - 10/2008 to present
. Conducted preformulation experiments to evaluate the solid state
pharmaceutical properties including solubility, stability,
crystallinity, hygroscopicity, ect. of small molecule drug development
candidates.
. Performed crystallization/characterization of freebase and salt forms
of small molecule drug candidates for the purpose of salt and
polymorph selection.
Biogen-Idec/Conforma Therapeutics Corporation, San Diego, CA
Associate Scientist II - 03/2004 to 10/2008
. Worked at the bench with small molecules as a synthetic organic
chemist.
. Generated new heterocyclic scaffolds targeting various kinase binding
sites which demonstrate anti-tumor activity.
. Designed and conducted experiments for small molecule route
development and lead optimization projects.
. Utilized knowledge of literature and patent searches to aid in target
identification and explore synthetic methodology design.
. Performed the stereospecific synthesis of a complex natural product
fragment as part of an on-going oncology research effort and published
its results.
. Generated libraries of compounds and provided sufficient
characterization data for inclusion in numerous patents.
Arena Pharmaceuticals Inc., San Diego, CA
Research Associate - 09/2001 to 01/ 2004
. Worked as a team member whose responsibility was the small-scale
synthesis and characterization of novel heterocyclic molecules serving
as 5HT2C agonists.
. Performed multi-gram synthesis of key compounds on the mole scale.
. Worked extensively with air-sensitive reagents, cross-coupling
organometallics and microwave chemistry while generating proprietary
seratonin agonists.
EDUCATION
The Pennsylvania State University, University Park, Pa.
MS, Organic Chemistry - 05/2001.
. Worked as a teaching assistant in an undergraduate organic chemistry
instrumentation laboratory.
. 9-month synthetic chemistry practicum with ViroPharma Inc., Exton, Pa.
. Instructed three semesters of undergraduate organic chemistry
laboratory (Chem 35) students, 20 students per lab section.
. 5 Semesters of graduate research experience with Dr. P. Maslak where I
synthesized novel spiroconjugated charge transfer dyes possessing
interesting optical properties
. 1 Semester of natural product research in the lab of Steven Weinreb.
The University of Alaska Fairbanks, Fairbanks, AK
BS, Natural Resources Management - 05/1992
PUBLICATIONS
[My paper]Brian Smith, Jeffrey Smith, James Tsai, Jeffrey Schultz, Charles
Gilson, Scott Estrada, Rita Chen, Douglas Park, Emily Prieto, Charlemagne
Gallardo, Dipanjan Sengupta, Peter Dosa, Jon Covel, Albert Ren, Robert
Webb, Nigel Beeley, Michael Martin, Michael Morgan, Stephen Espitia, Hazel
Saldana, Christina Bjenning, Kevin Whelan, Andrew Grottick, Frederique
Menzaghi, William Thomsen; "Discovery and Structure-Activity Relationship
of (1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin),
a Selective Serotinin 5-HT2C Receptor Agonist for the treatment of
Obesity"; Journal of Medicinal Cehmistry, (2008), 51 (2), 305-313.
Gilson III, C.A.; Le Brazidec, J.Y.; Zang, H.; Yang, C.; Burrows, F.;
Boehm, M.; "Stereoselective Synthesis of the C1-C13 Fragment of 2,3-Dihydro-
dorrigocin A"; Journal of Organic Chemistry (2005), 70(20), 8212-8215.
Gilson III, C.A.; Le Brazidec, J.Y.; Zang, H.; Yang, C.; Burrows, F.;
Boehm, M.; First synthesis of the C1-C13 fragment of dorrigocin A.
Abstract of Papers, 229th ACS National Meeting, San Diego, CA, March 13-17,
2005.
Smith, Brian M.; Smith, Jeffrey; Tsai, James H.; Schultz, Jeffrey A.;
Gilson, Charles; Chen, Rita; Estrada, Scott; Park, Douglas; Prieto, Emily;
Sengupta, Dipanjan; Saldana, Hazel; Thomsen, William; Kevin, Whelan;
Creehan, Kevin; Gonzalez, Lena; Menzaghi, Frederique; Bjenning, Christina;
Beeley, Nigel; Webb, Robert R.; Behan, Dominic. Discovery, SAR and
biology of 5-HT2C receptors for the treatment of obesity. Abstracts of
Papers, 229th ACS National Meeting, San Diego, CA, United States, March 13-
17, 2005 (2005),
Tsai, James H.; Smith, Brian M.; Chen, Rita; Prieto, Emily; Park, Douglas;
Smith, Jeffrey; Schultz, Jeffrey A.; Gallardo, Charlemagne; Estrada, Scott;
Fang, Sherry; Gilson, Charles; Thomsen, William; Saldana, Hazel; Bjenning,
Christina; Creehan, Kevin; Gonzalez, Lena; Whelan, Kevin; Webb, Robert R.;
Beeley, Nigel. Evaluation of selective 5-HT2C phenylpiperazine agonists
for the treatment of obesity. Abstracts of Papers, 229th ACS National
Meeting, San Diego, CA, United States, March 13-17, 2005 (2005),
Burbaum, Beverly W.; Gilson, Charles A., III; Aytes, Shelley; Estrada,
Scott A.; Sengupta, Dipanjan; Smith, Brian; Rey, Max; Weigl, Ulrich.
Processes for preparing 3-benzazepines. PCT Int. Appl. (2005), 143
pp. CODEN: PIXXD2 WO 200-***-**** A2 20050303 CAN 142:280072 AN
2005:182631
Schultz, Jeffrey A.; Smith, Brian M.; Smith, Jeffrey; Tsai, James H.;
Gilson, Charles; Estrada, Scott; Chen, Rita; Park, Douglas; Prieto, Emily;
Gallardo, Charlemagne; Sengupta, Dipanjan; Thomsen, William; Saldana,
Hazel; Bjenning, Christina; Creehan, Kevin; Gonzalez, Lena; Whelan, Kevin;
Webb, Robert R.; Beeley, Nigel. Synthesis and SAR of substituted
benzazepines as selective 5-HT2C agonists. Abstracts of Papers, 229th
ACS National Meeting, San Diego, CA, United States, March 13-17, 2005
(2005)
Smith, B.; Gilson III, C.A.; Schultz, J.; Smith, J.; "Benzazepine
Derivatives Useful for the Treatment of 5HC2C Receptor Associated
Diseases". International patent publication WO 2005/003096 (01/13/05).
Smith, B.; Schultz, J.; Gilson III, C.A.; Estrada, S.; "Benzazepine
Derivatives and Methods of Prophylaxis or Treatment of 5HC2C Receptor
Associated Diseases". International patent publication WO 2005/042490
(05/12/2005).
Smith, B.; Schultz, J.; Gilson III, C.A.; Estrada, S.; "Benzazepine
Derivatives and Methods of Prophylaxis or Treatment of 5HC2C Receptor
Associated Diseases". International patent publication WO 2005/042491
(05/12/2005).
Smith, B.; Smith, J.; Tsai, J.; Schultz, J; Gilson,C.A.; Estrada, S.; Chen,
R.; Park, D.M.; Prieto, E.; Gallardo, C.; "Discovery and SAR of New
Benzazepines as Potent and Selective 5HT2C Receptor Agonists for the
Treatment of Obesity".; Bioorganic & Medicinal Chemistry Letters; 2005; 15
(5); 1467-1470.
Smith, Brian; Gilson, Charles, III; Schultz, Jeffrey; Smith, Jeffrey. A
preparation of benzazepine derivatives, useful as 5HT2C receptor
modulators. PCT Int. Appl. (2005), 71 pp. CODEN: PIXXD2 WO
200-***-**** A1 20050113 CAN 142:134482 AN 2005:29313
Smith, Brian; Smith, Jeffrey; Chen, Rita; Covel, Jon; Dosa, Peter; Estrada,
Scott; Gilson, Charles; Park, Douglas; Prieto, Emily; Schultz, Jeffrey;
Tsai, James; Webb, Rob; Aytes, Shelley; Burbaum, Beverly; Fritch, John;
Sengupta, Dipanjan; Henshilwood, James; Reyes Saldana, Hazel; Thomsen,
William; Whelan, Kevin; Menzaghi, Frederique; Bjenning, Christina; Martin,
Michael; Chapman, Dennis; Maffuid, Paul; Beeley, Nigel; Chalmers, Derek;
Behan, Dominic. Discovery of APD356: A potent and selective 5-HT2C
receptor agonist for the treatment of obesity. Abstracts of Papers,
227th ACS National Meeting, Anaheim, CA, United States, March 28-April 1,
2004 (2004)
References are available upon request.
Hobbies
I am an avid outdoorsman and someone who possesses more than the average
amount of mechanical aptitude. I have a restored Boston Whaler fishing
boat which I currently use for marlin and tuna fishing. I also enjoy
riding and working on my Harley Davidson motorcycle.